Zimmer Biomet Holdings, Inc. Stock Mexican S.E.
Equities
ZBH *
US98956P1021
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,015 MXN | -3.16% | -.--% | +8.91% |
05-31 | Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says | MT |
05-31 | Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130 | MT |
Sales 2024 * | 7.76B 132B 10.58B | Sales 2025 * | 8.12B 138B 11.06B | Capitalization | 23.69B 403B 32.28B |
---|---|---|---|---|---|
Net income 2024 * | 986M 16.75B 1.34B | Net income 2025 * | 1.19B 20.15B 1.62B | EV / Sales 2024 * | 3.61 x |
Net Debt 2024 * | 4.34B 73.73B 5.91B | Net Debt 2025 * | 3.03B 51.54B 4.13B | EV / Sales 2025 * | 3.29 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
20.4
x | Employees | 18,000 |
Yield 2024 * |
0.84% | Yield 2025 * |
0.85% | Free-Float | 64.77% |
Latest transcript on Zimmer Biomet Holdings, Inc.
1 day | -3.16% | ||
1 month | -3.16% | ||
3 months | -4.28% | ||
6 months | +8.91% | ||
Current year | +8.91% |
Managers | Title | Age | Since |
---|---|---|---|
Ivan Tornos
CEO | Chief Executive Officer | 48 | 18-10-31 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 55 | 19-06-30 |
Nitin Goyal
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Higgins
BRD | Director/Board Member | 68 | 06-12-31 |
Betsy Bernard
BRD | Director/Board Member | 68 | 08-12-31 |
Mick Farrell
BRD | Director/Board Member | 51 | 14-12-11 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
+1.38% | 22.04B |
- Stock Market
- Equities
- ZBH Stock
- ZBH * Stock